TABLE I. Serogroup C meningococcal disease incidence by age group and region of residence (Brazil, 2001-2013).

Region	Age group (years)	Meningococcal disease serogroup C incidence (cases/100,000)
		2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011*	2012*	2013*
	< 1	3.98	2.84	4.67	6.24	6.19	7.71	6.92	7.09	8.78	9.50	4.15	2.82	3.03
	1-4	2.26	1.85	2.18	2.77	2.96	3.13	2.78	3.40	3.89	3.68	3.16	1.70	0.89
Brazil	5-9	0.95	1.06	0.90	1.50	1.41	1.61	1.61	1.71	2.00	2.03	1.87	2.05	1.42
	≥ 10	0.23	0.25	0.26	0.37	0.36	0.38	0.43	0.54	0.62	0.71	0.70	0.71	0.58
	Total	0.53	0.50	0.54	0.76	0.75	0.81	0.81	0.95	1.09	1.15	1.01	0.91	0.70
	< 1	-	-	-	0.49	1.59	-	-	1.86	-	1.63	-	1.30	1.60
	1-4	0.48	0.68	0.27	0.33	0.20	1.21	0.54	-	0.92	0.48	0.70	0.42	0.22
North	5-9	0.18	0.70	0.69	1.16	-	0.23	1.06	0.22	0.56	-	0.22	0.42	0.22
	≥ 10	0.32	0.22	0.17	0.35	0.03	0.20	0.27	0.38	0.47	0.29	0.20	0.29	0.39
	Total	0.31	0.33	0.24	0.45	0.07	0.30	0.38	0.35	0.51	0.30	0.24	0.30	0.38
	< 1	0.00	0.26	1.69	1.47	2.09	3.14	2.37	2.62	4.90	3.11	2.64	1.32	2.55
	1-4	0.93	0.41	0.52	0.57	0.93	0.58	0.90	1.18	1.95	0.91	1.09	0.94	0.50
Northeast	5-9	0.63	0.80	0.41	0.32	0.68	0.71	0.87	0.64	1.45	1.06	1.01	1.19	0.53
	≥ 10	0.17	0.22	0.11	0.22	0.25	0.26	0.28	0.35	0.48	0.61	0.50	0.58	0.41
	Total	0.29	0.30	0.20	0.28	0.38	0.38	0.42	0.48	0.76	0.71	0.62	0.67	0.46
	< 1	4.40	0.00	3.02	4.88	5.66	7.22	8.05	7.64	9.08	4.53	2.65	2.39	1.49
	1-4	1.51	1.62	0.33	0.72	2.64	3.53	2.81	3.30	3.63	3.62	2.13	0.81	0.66
Midwest	5-9	0.42	0.20	0.37	0.74	0.18	0.55	0.98	0.59	1.38	1.21	1.10	0.88	0.41
	≥ 10	0.20	0.12	0.17	0.21	0.18	0.35	0.31	0.41	0.46	0.59	0.45	0.39	0.44
	Total	0.41	0.25	0.26	0.38	0.46	0.72	0.67	0.74	0.89	0.90	0.65	0.48	0.47
	< 1	8.48	6.59	9.17	12.10	11.06	14.93	13.72	12.86	15.65	18.97	7.62	5.16	4.19
	1-4	4.25	3.59	4.60	5.87	5.83	6.17	5.32	6.97	7.27	7.90	6.41	3.38	1.64
Southeast	5-9	1.75	1.85	1.56	2.75	2.86	2.75	2.79	3.48	3.56	3.96	3.61	4.10	3.09
	≥ 10	0.26	0.34	0.41	0.57	0.54	0.56	0.67	0.82	0.92	1.05	1.13	1.10	0.88
	Total	0.81	0.80	0.94	1.29	1.25	1.32	1.33	1.59	1.71	1.92	1.70	1.51	1.13
	< 1	2.24	1.51	2.77	5.00	5.26	3.42	2.05	4.55	4.20	4.85	1.32	0.44	2.79
	1-4	1.40	1.22	1.55	2.14	1.96	1.93	1.90	1.43	1.53	1.11	1.56	0.35	0.41
South	5-9	0.29	0.12	0.60	1.24	0.60	1.99	0.62	0.83	0.23	0.83	0.69	0.47	0.26
	≥ 10	0.20	0.14	0.18	0.16	0.25	0.19	0.17	0.22	0.19	0.19	0.19	0.17	0.18
	Total	0.32	0.24	0.35	0.46	0.47	0.50	0.34	0.40	0.32	0.35	0.32	0.20	0.23

*: years in bold indicate period pos-vaccine implementation.